Launch of the HiMax® Plus Widebody™ Fixation System for Foot Fusions

Fusion Marketplace Changes Healthcare Traveler Experience

Fusion Marketplace is a traveler-first driven platform giving healthcare professionals the power to make decisions in their careers that they haven't been able to in the past.

Veranex Announces Investment From Summit Partners to Form Comprehensive Concept-to-Commercialization Medtech Services Company

As the first phase in building this global entity, Veranex has acquired three complementary solution providers: Ximedica, Quartesian, and Boston Healthcare Associates. By bringing these companies together, Veranex combines the industry’s key pillars of design and engineering, regulatory, clinical, and market access into a single-source solution.

CrossRoads® Extremity Systems, the global leader in Staple Compression Plates(SCP) and nitinol technology for the lower extremities, announced it has received FDA clearance and launched the HiMax® Plus Widebody Fixation System. HiMax® Plus is the only foot bone fusion system on the market to provide flush insertion, market-leading compression, and a wide bridge for enhanced stability. The features work in conjunction to provide improved implant performance with more efficiency in the operating room than alternative technologies. HiMax® Plus is CrossRoads’ latest addition to its Comprehensive Nitinol System.

Chad Hollis, VP of Research and Development and Co-Founder, stated “HiMax Plus shows our continued commitment to be the leader in the development of nitinol applications for the lower extremities. The HiMax family is born from years of fine-tuning and we believe the addition of HiMax Plus gives surgeons an enhanced nitinol implant that will be an optimal solution for all types of fusions.” CrossRoads will unveil this new system at the American College of Foot and Ankle Surgeons (ACFAS) Annual 2020 Meeting taking place in San Antonio, TX February 19th through February 22nd. CrossRoads will be exhibiting at booth #143.

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles